Amphivena Therapeutics appoints president and CEO
Amphivena Therapeutics Inc, a private clinical stage immuno-oncology company, has named Dr. Curtis L. Ruegg as president and CEO.
2 December 2019•3 mins read
Amphivena Therapeutics Inc, a private clinical stage immuno-oncology company, has named Dr. Curtis L. Ruegg as president and CEO.
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
11 hours ago · 1 min read
KKR and Hildred merge diagnostics businesses Sapphiros and binx health into Onvaro
12 hours ago · 2 mins read
Eir Partners-backed Porter acquires health plan analytics firm Pareto Intelligence
12 hours ago · 1 min read
Bain Capital’s LeanTaaS snaps up hospital care transition platform Aidin
12 hours ago · 2 mins read
Carlyle-backed Vantive agrees hemodialysis business sale to Rockwell Medical
12 hours ago · 2 mins read
Novacap completes OSI Maritime Systems acquisition as first Fund VII deal
12 hours ago · 2 mins read
Long Arc-backed Robertson Stephens adds Denver adviser Altius Financial
12 hours ago · 1 min read
